go-v.orgcodex
Menu
Page tools

codex · Chemistry

OX1001

Diagram for OX1001
OX1001 (saquinavir-NO) is an experimental drug being developed by OncoNOx currently undergoing clinical studies and investigations for the treatment of cancer. OX1001 is a nitrate ester analog of the approved HIV protease inhibitor, saquinavir. This modification increases the anti-cancer property w · image: Wikimedia Commons

OX1001 (saquinavir-NO) is an experimental drug being developed by OncoNOx currently undergoing clinical studies and investigations for the treatment of cancer. OX1001 is a nitrate ester analog of the approved HIV protease inhibitor, saquinavir. This modification increases the anti-cancer property while decreasing toxicity of the drug. OX1001 shows broad activity against cancer cells but is particularly effective against hematological, prostate, and melanoma cancers as seen in in vitro and in vivo studies.

Wikipedia contributors, "OX1001", Wikipedia, revision 1269859107, retrieved 20 November 2026, source, CC BY-SA 4.0.

More Chemistry · Search the codex